| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Fluid Therapy | 7 | 2019 | 628 | 1.85 | Why? |
| Interactive Ventilatory Support | 3 | 2018 | 25 | 1.49 | Why? |
| Noninvasive Ventilation | 13 | 2021 | 2329 | 1.37 | Why? |
| Respiratory Insufficiency | 11 | 2021 | 7301 | 1.14 | Why? |
| Cardiac Output | 4 | 2019 | 183 | 1.05 | Why? |
| Respiration, Artificial | 19 | 2021 | 22116 | 0.86 | Why? |
| Monitoring, Intraoperative | 2 | 2019 | 140 | 0.86 | Why? |
| Oxygen Inhalation Therapy | 6 | 2020 | 3629 | 0.82 | Why? |
| Echocardiography, Doppler, Pulsed | 1 | 2018 | 40 | 0.76 | Why? |
| Ventilator Weaning | 2 | 2021 | 536 | 0.73 | Why? |
| Rehydration Solutions | 1 | 2017 | 7 | 0.73 | Why? |
| Plasma Substitutes | 1 | 2017 | 24 | 0.72 | Why? |
| Isotonic Solutions | 1 | 2017 | 69 | 0.68 | Why? |
| Anesthesia | 2 | 2018 | 1236 | 0.68 | Why? |
| Community Networks | 1 | 2020 | 342 | 0.65 | Why? |
| Hemodynamics | 4 | 2019 | 1562 | 0.61 | Why? |
| Brain Injuries, Traumatic | 1 | 2020 | 381 | 0.59 | Why? |
| Patient Positioning | 3 | 2021 | 1505 | 0.59 | Why? |
| Prone Position | 3 | 2021 | 1861 | 0.55 | Why? |
| Critical Care | 11 | 2020 | 14081 | 0.55 | Why? |
| Work of Breathing | 1 | 2014 | 86 | 0.54 | Why? |
| Diaphragm | 2 | 2021 | 232 | 0.49 | Why? |
| Pulmonary Medicine | 1 | 2019 | 706 | 0.48 | Why? |
| Hospital Bed Capacity | 1 | 2020 | 1300 | 0.47 | Why? |
| Immunoglobulins | 1 | 2017 | 811 | 0.46 | Why? |
| Hypoxia | 5 | 2020 | 3626 | 0.45 | Why? |
| Thrombophilia | 2 | 2020 | 1935 | 0.43 | Why? |
| Medical Staff, Hospital | 1 | 2020 | 1258 | 0.41 | Why? |
| Shock | 1 | 2017 | 1868 | 0.40 | Why? |
| Intensive Care Units | 16 | 2021 | 29594 | 0.38 | Why? |
| Shock, Septic | 3 | 2017 | 1313 | 0.38 | Why? |
| Airway Management | 1 | 2019 | 1298 | 0.37 | Why? |
| Colloids | 2 | 2018 | 49 | 0.37 | Why? |
| Head Protective Devices | 2 | 2020 | 163 | 0.37 | Why? |
| Lung Injury | 1 | 2017 | 919 | 0.35 | Why? |
| Anesthesiology | 1 | 2018 | 1163 | 0.35 | Why? |
| Electric Impedance | 2 | 2020 | 283 | 0.34 | Why? |
| Hypercapnia | 2 | 2019 | 172 | 0.33 | Why? |
| Stress Disorders, Post-Traumatic | 1 | 2020 | 2963 | 0.27 | Why? |
| Cannula | 2 | 2020 | 750 | 0.27 | Why? |
| Pulmonary Disease, Chronic Obstructive | 5 | 2019 | 3832 | 0.26 | Why? |
| Blood Pressure | 4 | 2019 | 2198 | 0.26 | Why? |
| Cross-Over Studies | 4 | 2019 | 867 | 0.26 | Why? |
| Stroke Volume | 5 | 2019 | 2153 | 0.25 | Why? |
| Lung Neoplasms | 1 | 2020 | 3228 | 0.25 | Why? |
| Area Under Curve | 3 | 2020 | 2564 | 0.25 | Why? |
| Pleural Effusion | 2 | 2019 | 680 | 0.25 | Why? |
| Positive-Pressure Respiration | 3 | 2020 | 1160 | 0.24 | Why? |
| Radiography, Thoracic | 1 | 2019 | 5486 | 0.24 | Why? |
| Thrombosis | 3 | 2021 | 7504 | 0.23 | Why? |
| Pneumonia | 3 | 2019 | 5652 | 0.23 | Why? |
| Continuous Positive Airway Pressure | 3 | 2021 | 1187 | 0.23 | Why? |
| Coronary Artery Bypass | 2 | 2019 | 629 | 0.23 | Why? |
| Spontaneous Perforation | 1 | 2020 | 10 | 0.22 | Why? |
| Cardiography, Impedance | 1 | 2020 | 16 | 0.22 | Why? |
| Pneumonia, Viral | 12 | 2020 | 243684 | 0.21 | Why? |
| Muscles | 1 | 2021 | 152 | 0.21 | Why? |
| Omentum | 1 | 2020 | 23 | 0.21 | Why? |
| Coronavirus Infections | 12 | 2020 | 253789 | 0.21 | Why? |
| Italy | 11 | 2021 | 38444 | 0.21 | Why? |
| Vascular System Injuries | 1 | 2021 | 91 | 0.21 | Why? |
| Humans | 62 | 2021 | 930598 | 0.20 | Why? |
| Gallbladder | 1 | 2020 | 58 | 0.20 | Why? |
| ROC Curve | 4 | 2021 | 6024 | 0.20 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.20 | Why? |
| Immunoglobulin M | 1 | 2017 | 9091 | 0.20 | Why? |
| Anesthetics, General | 1 | 2019 | 12 | 0.20 | Why? |
| Internship and Residency | 1 | 2020 | 4987 | 0.19 | Why? |
| Hydroxyethyl Starch Derivatives | 1 | 2018 | 22 | 0.19 | Why? |
| Anesthesia, Intravenous | 1 | 2019 | 37 | 0.19 | Why? |
| Gangrene | 1 | 2020 | 122 | 0.19 | Why? |
| Tomography | 1 | 2020 | 183 | 0.19 | Why? |
| Hepatic Insufficiency | 1 | 2020 | 80 | 0.19 | Why? |
| Hypovolemia | 1 | 2019 | 65 | 0.19 | Why? |
| Betacoronavirus | 11 | 2020 | 204454 | 0.18 | Why? |
| Cholecystitis | 1 | 2020 | 141 | 0.18 | Why? |
| Male | 33 | 2021 | 367725 | 0.18 | Why? |
| Cholecystectomy | 1 | 2020 | 198 | 0.18 | Why? |
| Thrombin | 1 | 2021 | 325 | 0.17 | Why? |
| Aged | 27 | 2021 | 215776 | 0.17 | Why? |
| Cephalosporins | 1 | 2019 | 250 | 0.17 | Why? |
| Tracheostomy | 2 | 2021 | 1963 | 0.17 | Why? |
| Tidal Volume | 4 | 2021 | 565 | 0.16 | Why? |
| Osteopontin | 1 | 2017 | 96 | 0.16 | Why? |
| Infusions, Intravenous | 2 | 2017 | 1224 | 0.16 | Why? |
| Acinetobacter Infections | 1 | 2019 | 273 | 0.16 | Why? |
| Wakefulness | 1 | 2021 | 598 | 0.16 | Why? |
| Anesthetics, Inhalation | 1 | 2017 | 82 | 0.15 | Why? |
| Respiratory Physiological Phenomena | 1 | 2017 | 157 | 0.15 | Why? |
| Hemoperfusion | 1 | 2020 | 260 | 0.15 | Why? |
| Accidental Falls | 1 | 2020 | 448 | 0.15 | Why? |
| Pandemics | 15 | 2021 | 389249 | 0.15 | Why? |
| Accidents, Traffic | 1 | 2020 | 464 | 0.15 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.15 | Why? |
| Laparotomy | 1 | 2017 | 241 | 0.15 | Why? |
| Drainage | 1 | 2019 | 414 | 0.15 | Why? |
| Anesthesia, Cardiac Procedures | 1 | 2017 | 145 | 0.14 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.14 | Why? |
| Middle Aged | 23 | 2021 | 270681 | 0.14 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.14 | Why? |
| Predictive Value of Tests | 3 | 2019 | 9537 | 0.14 | Why? |
| Klebsiella Infections | 1 | 2019 | 466 | 0.14 | Why? |
| Female | 29 | 2021 | 380317 | 0.14 | Why? |
| Kaplan-Meier Estimate | 2 | 2021 | 4260 | 0.14 | Why? |
| Rats, Sprague-Dawley | 1 | 2017 | 987 | 0.14 | Why? |
| Respiration Disorders | 1 | 2020 | 526 | 0.13 | Why? |
| Critical Illness | 7 | 2019 | 17281 | 0.13 | Why? |
| Positron-Emission Tomography | 1 | 2019 | 802 | 0.13 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2021 | 634 | 0.13 | Why? |
| Ultrasonography | 2 | 2021 | 4409 | 0.13 | Why? |
| Heart Valve Diseases | 1 | 2018 | 355 | 0.13 | Why? |
| Expert Testimony | 1 | 2017 | 658 | 0.13 | Why? |
| Coronary Artery Disease | 2 | 2019 | 2570 | 0.13 | Why? |
| Research Report | 1 | 2017 | 376 | 0.13 | Why? |
| Administration, Intranasal | 1 | 2017 | 1132 | 0.13 | Why? |
| Treatment Outcome | 10 | 2021 | 51732 | 0.12 | Why? |
| Respiratory Mechanics | 1 | 2017 | 585 | 0.12 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 1165 | 0.12 | Why? |
| Desensitization, Immunologic | 1 | 2017 | 574 | 0.12 | Why? |
| Hypnotics and Sedatives | 1 | 2017 | 624 | 0.11 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 1115 | 0.11 | Why? |
| Allergens | 1 | 2017 | 728 | 0.11 | Why? |
| Lung | 4 | 2021 | 31049 | 0.11 | Why? |
| Operating Rooms | 2 | 2019 | 1841 | 0.11 | Why? |
| Piperidines | 1 | 2017 | 795 | 0.11 | Why? |
| Pneumothorax | 1 | 2019 | 758 | 0.11 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.11 | Why? |
| Sepsis | 2 | 2017 | 3517 | 0.10 | Why? |
| Rats | 1 | 2017 | 2764 | 0.10 | Why? |
| Randomized Controlled Trials as Topic | 5 | 2021 | 10649 | 0.10 | Why? |
| Double-Blind Method | 2 | 2018 | 5988 | 0.10 | Why? |
| Intubation | 2 | 2021 | 437 | 0.10 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.09 | Why? |
| Postoperative Complications | 2 | 2018 | 5861 | 0.09 | Why? |
| Asthma | 2 | 2017 | 4383 | 0.09 | Why? |
| Acute Kidney Injury | 2 | 2020 | 5762 | 0.09 | Why? |
| Heart Rate | 1 | 2017 | 1527 | 0.09 | Why? |
| Neurosurgical Procedures | 1 | 2019 | 1738 | 0.08 | Why? |
| Adult | 12 | 2021 | 244371 | 0.08 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.08 | Why? |
| Aged, 80 and over | 10 | 2021 | 88759 | 0.08 | Why? |
| Oxygen | 1 | 2019 | 3715 | 0.08 | Why? |
| Masks | 2 | 2019 | 8528 | 0.07 | Why? |
| Liver Diseases | 1 | 2021 | 2698 | 0.07 | Why? |
| Pulmonary Gas Exchange | 2 | 2019 | 414 | 0.07 | Why? |
| Ventilators, Mechanical | 1 | 2017 | 2193 | 0.07 | Why? |
| Inflammation | 2 | 2017 | 13255 | 0.07 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.07 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.07 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.07 | Why? |
| Elective Surgical Procedures | 2 | 2019 | 5338 | 0.07 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.07 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2020 | 5002 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.06 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.06 | Why? |
| Europe | 1 | 2019 | 12702 | 0.06 | Why? |
| Anti-Bacterial Agents | 3 | 2019 | 10083 | 0.06 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Thrombomodulin | 1 | 2021 | 121 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.05 | Why? |
| Autopsy | 2 | 2021 | 3495 | 0.05 | Why? |
| Air Pressure | 1 | 2019 | 119 | 0.05 | Why? |
| Fibrin | 1 | 2020 | 145 | 0.05 | Why? |
| Reproducibility of Results | 3 | 2021 | 11304 | 0.05 | Why? |
| Lung Compliance | 1 | 2020 | 243 | 0.05 | Why? |
| Vasoconstriction | 1 | 2020 | 153 | 0.05 | Why? |
| Endpoint Determination | 1 | 2020 | 344 | 0.05 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.05 | Why? |
| Manikins | 1 | 2021 | 466 | 0.05 | Why? |
| Receptors, Interleukin-4 | 1 | 2017 | 11 | 0.05 | Why? |
| Administration, Sublingual | 1 | 2017 | 41 | 0.05 | Why? |
| Patient Comfort | 1 | 2019 | 74 | 0.04 | Why? |
| Anesthetics, Intravenous | 1 | 2019 | 98 | 0.04 | Why? |
| Aspergillus | 1 | 2021 | 347 | 0.04 | Why? |
| B-Lymphocytes, Regulatory | 1 | 2017 | 24 | 0.04 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Dose-Response Relationship, Drug | 2 | 2018 | 3776 | 0.04 | Why? |
| Infarction | 1 | 2020 | 206 | 0.04 | Why? |
| Heart Failure | 1 | 2019 | 6638 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.04 | Why? |
| Volatilization | 1 | 2017 | 110 | 0.04 | Why? |
| Half-Life | 1 | 2017 | 298 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.04 | Why? |
| Perioperative Period | 1 | 2018 | 276 | 0.04 | Why? |
| Interleukin-13 | 1 | 2017 | 204 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.04 | Why? |
| Acinetobacter baumannii | 1 | 2019 | 378 | 0.04 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.04 | Why? |
| Interleukin-4 | 1 | 2017 | 367 | 0.04 | Why? |
| Acute Disease | 2 | 2020 | 6029 | 0.04 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.04 | Why? |
| Injections, Subcutaneous | 1 | 2017 | 647 | 0.04 | Why? |
| Smokers | 1 | 2021 | 550 | 0.04 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.04 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.04 | Why? |
| Single-Blind Method | 1 | 2019 | 1283 | 0.04 | Why? |
| Cardiotonic Agents | 1 | 2018 | 418 | 0.04 | Why? |
| Compassionate Use Trials | 1 | 2019 | 632 | 0.04 | Why? |
| Body Fluids | 1 | 2019 | 451 | 0.04 | Why? |
| Respiratory Rate | 1 | 2019 | 691 | 0.04 | Why? |
| Blood Coagulation Tests | 1 | 2020 | 855 | 0.03 | Why? |
| Thrombelastography | 1 | 2020 | 627 | 0.03 | Why? |
| Anesthesia, General | 1 | 2019 | 470 | 0.03 | Why? |
| Fibrinogen | 1 | 2020 | 1048 | 0.03 | Why? |
| Mitral Valve | 1 | 2018 | 342 | 0.03 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.03 | Why? |
| Russia | 1 | 2018 | 989 | 0.03 | Why? |
| Klebsiella pneumoniae | 1 | 2019 | 658 | 0.03 | Why? |
| Blood Gas Analysis | 1 | 2017 | 893 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.03 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2021 | 861 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Survival Analysis | 2 | 2017 | 7592 | 0.03 | Why? |
| Erythrocyte Transfusion | 1 | 2017 | 386 | 0.03 | Why? |
| Vasoconstrictor Agents | 1 | 2017 | 714 | 0.03 | Why? |
| Immune Tolerance | 1 | 2017 | 608 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2020 | 2275 | 0.03 | Why? |
| Nutrition Assessment | 1 | 2017 | 527 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2019 | 1647 | 0.03 | Why? |
| Nutritional Support | 1 | 2017 | 447 | 0.03 | Why? |
| Intubation, Intratracheal | 2 | 2018 | 3962 | 0.03 | Why? |
| Risk Assessment | 1 | 2016 | 25439 | 0.03 | Why? |
| Early Diagnosis | 1 | 2021 | 2443 | 0.03 | Why? |
| Biopsy | 1 | 2021 | 2811 | 0.03 | Why? |
| Patient Care Planning | 1 | 2017 | 582 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2018 | 1262 | 0.03 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.03 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.03 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2017 | 698 | 0.03 | Why? |
| Resuscitation | 1 | 2017 | 638 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.03 | Why? |
| Animals | 2 | 2017 | 78931 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2019 | 2886 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.02 | Why? |
| Dermatitis, Atopic | 1 | 2017 | 714 | 0.02 | Why? |
| Disease Progression | 2 | 2019 | 13580 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Laparoscopy | 1 | 2020 | 1532 | 0.02 | Why? |
| Recovery of Function | 1 | 2018 | 2461 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Equipment Design | 1 | 2019 | 3095 | 0.02 | Why? |
| Renal Replacement Therapy | 1 | 2017 | 1530 | 0.02 | Why? |
| New York City | 1 | 2020 | 7432 | 0.02 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.02 | Why? |
| Forecasting | 1 | 2017 | 4492 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.01 | Why? |
| Research Design | 1 | 2019 | 5830 | 0.01 | Why? |
| Mortality | 1 | 2019 | 7132 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.01 | Why? |
| Brazil | 1 | 2018 | 12582 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2017 | 9335 | 0.01 | Why? |
| Influenza, Human | 1 | 2019 | 10779 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.01 | Why? |
| China | 1 | 2017 | 50654 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |